Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Myriam Benamor
The Efficacy of Teriflunomide in Patients Who Received Prior Disease-Modifying Treatments: Subgroup Analyses of the Teriflunomide Phase 3 TEMSO and TOWER Studies
Multiple Sclerosis
Neurology
Characterizing Lymphocyte Counts and Infection Rates With Long-Term Teriflunomide Treatment: Pooled Analysis of Clinical Trials
Multiple Sclerosis
Neurology
Related publications
Clinical Efficacy of Teriflunomide Over a Fixed 2-Year Duration in the TOWER Study
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Clinical Recommendations on the Use of Teriflunomide
Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova
Psychiatry
Mental Health
Neurology
Teriflunomide Treatment Reduces B Cells in Patients With MS
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Tolerability and Discontinuation Rates in Teriflunomide-Treated Patients. A Real-World Clinical Experience
Neurosciences
Psychiatry
Mental Health
Neurology
Teriflunomide in the Treatment of Multiple Sclerosis: Current Evidence and Future Prospects
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Efficacy and Safety of Sirukumab in Japanese Patients With Moderate to Severe Rheumatoid Arthritis Inadequately Controlled by Disease Modifying Anti-Rheumatic Drugs: Subgroup Analysis of a Phase 3 Study
Modern Rheumatology
Medicine
Rheumatology
Comparing Outcomes From Clinical Studies of Oral Disease-Modifying Therapies (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Relapsing MS: Assessing Absolute Differences Using a Number Needed to Treat Analysis
Multiple Sclerosis and Related Disorders
Medicine
Neurology
Efficacy and Safety of Trabectedin or Dacarbazine for the Treatment of Patients With Uterine Leiomyosarcoma After Prior Chemotherapy: A Subgroup Analysis of the Randomized Phase 3 SAR-3007 Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Pnd60 - Cost-Effectiveness of Teriflunomide for the Treatment of Relapsing-Remitting Multiple Sclerosis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental